These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 26796430)
1. Cancer vaccines: limited success but the research should remain viable. Baxevanis CN; Perez SA Expert Rev Vaccines; 2016 Jun; 15(6):677-80. PubMed ID: 26796430 [No Abstract] [Full Text] [Related]
2. Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy. Yu WD; Sun G; Li J; Xu J; Wang X Cancer Lett; 2019 Jun; 452():66-70. PubMed ID: 30902563 [TBL] [Abstract][Full Text] [Related]
3. CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy. Kranz LM; Beck JD; Grunwitz C; Hotz C; Vormehr M; Diken M Hum Vaccin Immunother; 2017 Oct; 13(10):2272-2279. PubMed ID: 28846471 [No Abstract] [Full Text] [Related]
4. Are peptide vaccines viable in combination with other cancer immunotherapies? Ohtake J; Sasada T Future Oncol; 2017 Aug; 13(18):1577-1580. PubMed ID: 28776424 [No Abstract] [Full Text] [Related]
5. [The Nobel prize in Medicine 2018 - A revolution in cancer management]. Gunnarsson O Laeknabladid; 2018 Nov; 104(11):489. PubMed ID: 30375979 [No Abstract] [Full Text] [Related]
6. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Rosenberg SA Immunol Today; 1997 Apr; 18(4):175-82. PubMed ID: 9136454 [No Abstract] [Full Text] [Related]
7. Immunotherapy of cancer: targeting cancer during active disease or during dormancy? Shah SA; Zarei M; Manjili SH; Guruli G; Wang XY; Manjili MH Immunotherapy; 2017 Sep; 9(11):943-949. PubMed ID: 29338608 [TBL] [Abstract][Full Text] [Related]
8. The dawn of vaccines for cancer prevention. Finn OJ Nat Rev Immunol; 2018 Mar; 18(3):183-194. PubMed ID: 29279613 [TBL] [Abstract][Full Text] [Related]
9. Decoding the human immune system to transform the future of global disease prevention and control. Koff WC; Schenkelberg T Expert Rev Vaccines; 2016 Oct; 15(10):1235-6. PubMed ID: 27010379 [No Abstract] [Full Text] [Related]
11. Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells. Joalland N; Scotet E Front Immunol; 2020; 11():992. PubMed ID: 32528477 [TBL] [Abstract][Full Text] [Related]
12. [Immunotherapies of cancer: Is there any impact on patient cognitive functions?]. Castel H; Joly F Med Sci (Paris); 2020; 36(8-9):695-699. PubMed ID: 32821042 [No Abstract] [Full Text] [Related]
13. Cancer Immunotherapy and endocrinology: A new opportunity for multidisciplinary collaboration. Zafon Llopis C Endocrinol Diabetes Nutr; 2017 Nov; 64(9):461-463. PubMed ID: 29050701 [No Abstract] [Full Text] [Related]
14. Apoptotic vesicles as tumor vaccine. Horrevorts SK; Garcia-Vallejo JJ; van Vliet SJ; van de Loosdrecht AA; van Kooyk Y; de Gruijl TD Immunotherapy; 2016; 8(1):5-8. PubMed ID: 26641072 [No Abstract] [Full Text] [Related]
19. Booming cancer immunotherapy fighting tumors. Li D; Wang W Sci China Life Sci; 2017 Dec; 60(12):1445-1449. PubMed ID: 29170888 [No Abstract] [Full Text] [Related]